, Singapore

Daily Markets Briefing: STI up 0.48%

Expect some gains today.

The Straits Times Index (STI) ended 16.42 points or 0.48% higher to 3466.38, taking the year-to-date performance to +1.86%. 

The top active stocks were OCBC Bank, which gained 0.39%, DBS, which gained 0.68%, UOB, which gained 0.98%, Singtel, which declined 0.59% and Venture, with a 2.10% advance.

The FTSE ST Mid Cap Index gained 0.48%, whilst the FTSE ST Small Cap Index rose 0.32%.

OCBC Investment Research noted that the Dow Jones Industrial Average gained more than 400 points Tuesday as US stocks surged thanks to a less-aggressive stance on trade taken by Chinese President Xi Jinping.

Nine out of 11 S&P 500 industries ended higher, led by Energy (3.32%) and Information Technology (2.48%), whilst Utilities (-0.72%) and Real Estate (-0.71%) bucked the trend.

"The strength on Wall Street overnight after Chinese President Xi’s conciliatory comments on tariffs is likely to provide a modest boost to the local bourse today," OCBC said.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare